This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Meric, F. Articles by Hung, M.-C. Search for Related Content PubMed PubMed Citation Articles by Meric, F. Articles by Hung, M.-C.

Expression Profile of Tyrosine Kinases in Breast Cancer¹

Departments of Surgical Oncology [F. M., H. Z., M-C. H.], Molecular and Cellular Oncology [W-P. L., M-C. H.], and Pathology [A. S.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, and Department of Biological Chemistry, University of California at Davis Cancer Center, Sacramento, California 95817 [H-J. K.]

The tyrosine kinase (TK) family includes many growth factor receptors, cell cycle regulators, and oncoproteins. Moreover, the receptor TKs HER2/neu and epidermal growth factor receptor are overexpressed in a subgroup of breast tumors and correlate with more aggressive behavior. Thus, TKs are being actively pursued as therapeutic targets. The purpose of this study was to determine the expression pattern of TKs in breast cancer. Reverse transcription-PCR was performed with degenerate primers based on conserved motifs of the catalytic domains of TKs, and the identities of the reverse transcription-PCR products were determined by digestion with a panel of restriction enzymes. Using a TK display assay, we studied the TK profiles of 13 breast cancer cell lines and two normal immortalized breast epithelial cell lines. The TK display assay reproducibly demonstrated known differences in HER-2/neu expression between cell lines. Several TKs, including receptor TKs Axl, Cak, fibroblast growth factor receptor 4, HEK8, HER2/neu, c-MET, RET, and nonreceptor TKs ARG, BRK, Janus kinase 1, Rak, and YES were detected in breast cancer cells. Several kinases were differentially expressed among the cell lines. Similar TK profiles were found using RNA from human breast tumors. We conclude that there is significant variability in the TK expression pattern of breast cancers. This variability should be considered when selecting TK inhibitors to treat patients.

This article has been cited by other articles:

				Aaron. P. Brown, J. Chen, Y. J. Hitchcock, A. Szabo, D. C. Shrieve, and Jonathan. D. Tward The Risk of Second Primary Malignancies up to Three Decades after the Treatment of Differentiated Thyroid Cancer J. Clin. Endocrinol. Metab., February 1, 2008; 93(2): 504 - 515. [Abstract] [Full Text] [PDF]

				V. A. Korshunov, M. Daul, M. P. Massett, and B. C. Berk Axl Mediates Vascular Remodeling Induced by Deoxycorticosterone Acetate Salt Hypertension Hypertension, December 1, 2007; 50(6): 1057 - 1062. [Abstract] [Full Text] [PDF]

				J.-D. Lay, C.-C. Hong, J.-S. Huang, Y.-Y. Yang, C.-Y. Pao, C.-H. Liu, Y.-P. Lai, G.-M. Lai, A.-L. Cheng, I.-J. Su, et al. Sulfasalazine Suppresses Drug Resistance and Invasiveness of Lung Adenocarcinoma Cells Expressing AXL Cancer Res., April 15, 2007; 67(8): 3878 - 3887. [Abstract] [Full Text] [PDF]

				T. Nakamura, I. J. Fidler, and K. R. Coombes Gene Expression Profile of Metastatic Human Pancreatic Cancer Cells Depends on the Organ Microenvironment Cancer Res., January 1, 2007; 67(1): 139 - 148. [Abstract] [Full Text] [PDF]

				V. A. Korshunov, A. M. Mohan, M. A. Georger, and B. C. Berk Axl, A Receptor Tyrosine Kinase, Mediates Flow-Induced Vascular Remodeling Circ. Res., June 9, 2006; 98(11): 1446 - 1452. [Abstract] [Full Text] [PDF]

				P. Vajkoczy, P. Knyazev, A. Kunkel, H.-H. Capelle, S. Behrndt, H. von Tengg-Kobligk, F. Kiessling, U. Eichelsbacher, M. Essig, T.-A. Read, et al. Dominant-negative inhibition of the Axl receptor tyrosine kinase suppresses brain tumor cell growth and invasion and prolongs survival PNAS, April 11, 2006; 103(15): 5799 - 5804. [Abstract] [Full Text] [PDF]

				J. Zhang, H. Ren, P. Yuan, W. Lang, L. Zhang, and L. Mao Down-regulation of Hepatoma-Derived Growth Factor Inhibits Anchorage-Independent Growth and Invasion of Non-Small Cell Lung Cancer Cells Cancer Res., January 1, 2006; 66(1): 18 - 23. [Abstract] [Full Text] [PDF]

				S. J. Holland, M. J. Powell, C. Franci, E. W. Chan, A. M. Friera, R. E. Atchison, J. McLaughlin, S. E. Swift, E. S. Pali, G. Yam, et al. Multiple Roles for the Receptor Tyrosine Kinase Axl in Tumor Formation Cancer Res., October 15, 2005; 65(20): 9294 - 9303. [Abstract] [Full Text] [PDF]

				H.-Y. Chen, C.-H. Shen, Y.-T. Tsai, F.-C. Lin, Y.-P. Huang, and R.-H. Chen Brk Activates Rac1 and Promotes Cell Migration and Invasion by Phosphorylating Paxillin Mol. Cell. Biol., December 15, 2004; 24(24): 10558 - 10572. [Abstract] [Full Text] [PDF]

				Y.-M. Wu, D. R. Robinson, and H.-J. Kung Signal Pathways in Up-regulation of Chemokines by Tyrosine Kinase MER/NYK in Prostate Cancer Cells Cancer Res., October 15, 2004; 64(20): 7311 - 7320. [Abstract] [Full Text] [PDF]

				Y. Liao and M.-C. Hung Regulation of the Activity of p38 Mitogen-Activated Protein Kinase by Akt in Cancer and Adenoviral Protein E1A-Mediated Sensitization to Apoptosis Mol. Cell. Biol., October 1, 2003; 23(19): 6836 - 6848. [Abstract] [Full Text] [PDF]

				L. Xia, D. Robinson, A.-H. Ma, H.-C. Chen, F. Wu, Y. Qiu, and H.-J. Kung Identification of Human Male Germ Cell-associated Kinase, a Kinase Transcriptionally Activated by Androgen in Prostate Cancer Cells J. Biol. Chem., September 13, 2002; 277(38): 35422 - 35433. [Abstract] [Full Text] [PDF]